Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial

AIMS/HYPOTHESIS: This study aimed to investigate the acute renal effects of the glucagon-like peptide-1 receptor agonist (GLP-1RA) exenatide in type 2 diabetes patients. METHODS: We included overweight (BMI 25–40 kg/m(2)) men and postmenopausal women, aged 35–75 years with type 2 diabetes (HbA(1c) 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Tonneijck, Lennart, Smits, Mark M., Muskiet, Marcel H. A., Hoekstra, Trynke, Kramer, Mark H. H., Danser, A. H. Jan, Diamant, Michaela, Joles, Jaap A., van Raalte, Daniël H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901099/
https://www.ncbi.nlm.nih.gov/pubmed/27038451
http://dx.doi.org/10.1007/s00125-016-3938-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901099/
https://www.ncbi.nlm.nih.gov/pubmed/27038451
http://dx.doi.org/10.1007/s00125-016-3938-z

Ejemplares similares